Ultrasound Technique for Spinal Tap Assessment

No longer recruiting at 1 trial location
FF
AK
Overseen ByAmina Keita
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Thomas Jefferson University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new ultrasound technique to measure pressure inside the skull for individuals with conditions like idiopathic intracranial hypertension, which causes increased brain pressure. The technique uses tiny microbubbles (perflutren lipid microsphere, a type of contrast agent) and sound waves to estimate pressure without an invasive spinal tap. If successful, this could simplify and improve the safety of diagnosing and monitoring these conditions. Ideal participants have conditions requiring a spinal tap to check brain pressure and are not allergic to certain contrast agents. As a Phase 2 trial, the research focuses on assessing the treatment's effectiveness in an initial, smaller group of people.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that this ultrasound technique is safe for spinal tap assessment?

Previous studies have safely used a substance called perflutren lipid microsphere to enhance ultrasound images. Research shows it works effectively and is generally safe for adults, including older adults. Most side effects are mild, such as headaches or nausea, and serious issues are rare. Thus, the treatment is considered safe for people.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores a new ultrasound technique for assessing spinal fluid pressure, potentially improving the accuracy of diagnosing conditions related to intracranial pressure (ICP). Unlike traditional spinal taps, which can be invasive and uncomfortable, this method uses perflutren lipid microsphere as a contrast agent, making the procedure less invasive and possibly safer. This innovation could lead to quicker, more precise diagnostics, sparing patients the discomfort and risks associated with traditional lumbar punctures.

What evidence suggests that the SHAPE technique is effective for monitoring intracranial pressure?

Research has shown that the SHAPE technique, which participants in this trial will experience, uses tiny bubbles called perflutren lipid microspheres and holds promise for measuring pressure inside the skull. This method employs ultrasound to activate these bubbles, enhancing image quality. Studies have found that it can estimate pressures in various body parts, such as the heart and other tissues, by observing bubble behavior. The bubbles help create clear images sensitive to pressure changes, crucial for diagnosing conditions like idiopathic intracranial hypertension, which involves high pressure around the brain. This technique could provide a noninvasive way to monitor brain pressure, potentially leading to better patient outcomes.678910

Are You a Good Fit for This Trial?

This trial is for adults over the age of 18 who are scheduled to undergo a lumbar puncture, commonly known as a spinal tap, to measure intracranial pressure (ICP).

Inclusion Criteria

I am scheduled for a spinal tap to check pressure in my brain.
I am over 18 years old.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo noninvasive ultrasound-based imaging using the SHAPE technique to estimate intracranial pressure

1 year

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Perflutren lipid microsphere
Trial Overview The SHAPE technique using Perflutren lipid microsphere contrast agents in ultrasound imaging is being tested as a noninvasive method to estimate ICP. This could be an alternative to direct measurement methods like lumbar punctures.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: SHAPE for ICP diagnosisExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Thomas Jefferson University

Lead Sponsor

Trials
475
Recruited
189,000+

Mayo Clinic

Collaborator

Trials
3,427
Recruited
3,221,000+

Published Research Related to This Trial

Low intensity pulsed ultrasound (LIPUS) can be effectively delivered to specific regions of lumbar intervertebral discs (IVDs) using advanced simulation techniques, showing a significant focal intensity gain of 5-168, which may enhance healing of injured or degenerated disc tissues.
The simulations indicate that LIPUS treatment can be safely applied with minimal temperature increase (<1 °C) in the target area, suggesting its potential as a non-invasive option for managing discogenic lower back pain.
In silico feasibility assessment of extracorporeal delivery of low-intensity pulsed ultrasound to intervertebral discs within the lumbar spine.Adams, MS., Lotz, JC., Diederich, CJ.[2022]
In a study of 27 patients with failed back surgery syndrome, ultrasound-guided facet joint injections significantly reduced pain levels over six months, with a notable decrease in pain rating scores from 7.0 to 6.0 (p=0.006).
The injections also led to a significant improvement in lumbar flexion, increasing from 50.0° at baseline to 70.0° by the sixth month (p<0.001), indicating enhanced mobility without any reported complications.
Does ultrasound-guided facet joint injection reduce pain and improve mobility in patients with failed back surgery syndrome?Çırak, M., Çağlar Okur, S.[2021]

Citations

Ultrasound Technique for Spinal Tap AssessmentPerflutren lipid microsphere is unique because it uses ultrasound to activate tiny bubbles that can enhance imaging and potentially improve the precision of ...
Study Details | NCT06571786 | SHAPE for ICP AssessmentDrug : Perflutren lipid microsphere. Definity ( Lantheus Medical Imaging, N ... data with pressures obtained using lumbar puncture (reference standard) ...
Annual Meeting of the American Society of NeuroimagingMethods: The echocardiographers have turned to Definity, an injectable suspension of perflutren lipid microspheres to increase the image quality ...
Sonothrombolysis: State-of-the-Art and Potential Applications ...Infarct volume percent was lower for rabbits treated with lipid MB + US, 3 μm MB + US, and tagged 3 μm MB + US compared with controls. Microbubble groups had ...
Perflutren lipid microspheres for echocardiogram contrastBackground Perflutren lipid microsphere suspension, sold under the brand name Definity®, is a microbubble ultrasound contrast agent.
Perflutren: Uses, Interactions, Mechanism of ActionPerflutren, a diagnostic drug that is intended to be used for contrast enhancement during the indicated echocardiographic procedures, comprised of lipid-coated ...
Perflutren lipid microsphere (intravenous route)Safety and efficacy have been established. Geriatric. Appropriate studies performed to date have not demonstrated geriatric-specific problems ...
Definity - accessdata.fda.govAfter activation, each vial contains a maximum of 1.2 X 1010 perflutren lipid microspheres, and about 150 microL/mL (1.1 mg/mL) octafluoropropane [see ...
Perflutren Uses, Side Effects & WarningsPerflutren is an ultrasound contrast agent that is used to improve the quality of an echocardiogram (ultrasound of the heart).
10.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/29573815/
Safety of Lumbar Puncture Performed on Dual Antiplatelet ...Performing LPs in the setting of dual antiplatelet therapy may not pose an increased risk of serious complications.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security